85 related articles for article (PubMed ID: 10982521)
1. Inadequate proof of adverse outcome due to the use of fluconazole in critically ill patients.
Blot SI; Hoste EA; Vandewoude KH; Colardyn FA
Arch Surg; 2000 Sep; 135(9):1114. PubMed ID: 10982521
[No Abstract] [Full Text] [Related]
2. Fluconazole prophylaxis for critically ill patients at high risk for Candida infection.
Garbino J
Clin Infect Dis; 2005 Dec; 41(11):1690-1. PubMed ID: 16267753
[No Abstract] [Full Text] [Related]
3. Pharmacokinetic evaluation of fluconazole in critically ill patients.
Sinnollareddy M; Peake SL; Roberts MS; Playford EG; Lipman J; Roberts JA
Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1431-40. PubMed ID: 21883033
[TBL] [Abstract][Full Text] [Related]
4. Impact of fluconazole administration on outcomes in critically ill patients.
Garrelts JC; Schroeder TR; Harrison PB
Ann Pharmacother; 2004 Oct; 38(10):1588-92. PubMed ID: 15340132
[TBL] [Abstract][Full Text] [Related]
5. Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance.
Rocco TR; Reinert SE; Simms HH
Arch Surg; 2000 Feb; 135(2):160-5. PubMed ID: 10668874
[TBL] [Abstract][Full Text] [Related]
6. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
7. Antifungal drug resistance: limited data, dramatic impact?
Rogers TR
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():7-11. PubMed ID: 16701982
[TBL] [Abstract][Full Text] [Related]
8. The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients.
Magill SS; Swoboda SM; Johnson EA; Merz WG; Pelz RK; Lipsett PA; Hendrix CW
Diagn Microbiol Infect Dis; 2006 Aug; 55(4):293-301. PubMed ID: 16698215
[TBL] [Abstract][Full Text] [Related]
9. Rapid determination of fluconazole susceptibilities for clinical specimens with possible polymicrobial Candida spp.
Chiew YF; Inwood H
N Z Med J; 2007 Jun; 120(1255):U2567. PubMed ID: 17546112
[No Abstract] [Full Text] [Related]
10. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole prevents yeast infections in women with HIV.
AIDS Patient Care STDS; 1996 Oct; 10(5):310. PubMed ID: 11361529
[No Abstract] [Full Text] [Related]
12. Candidiasis in immune-compromised women.
Cadman J
GMHC Treat Issues; 1997; 11(7-8):18. PubMed ID: 11364644
[TBL] [Abstract][Full Text] [Related]
13. Candida lusitaniae infections in the era of fluconazole availability.
Hawkins JL; Baddour LM
Clin Infect Dis; 2003 Jan; 36(2):e14-8. PubMed ID: 12522762
[TBL] [Abstract][Full Text] [Related]
14. [Prophylactic antifungal treatment in critically ill patients. A survey of a Cochrane review].
Christensen S; Buhl M; Tønnesen EK
Ugeskr Laeger; 2008 Jan; 170(1):36-9. PubMed ID: 18208713
[No Abstract] [Full Text] [Related]
15. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
[TBL] [Abstract][Full Text] [Related]
16. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole therapy for Candida albicans urinary tract infections in infants.
Triolo V; Gari-Toussaint M; Casagrande F; Garraffo R; Dageville C; Boutté P; Bérard E
Pediatr Nephrol; 2002 Jul; 17(7):550-3. PubMed ID: 12172774
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between in vitro susceptibility to antifungal drugs and the clinical evolution of patients with candidiasis and cryptococcosis].
Viudes A; Cantón E; Pemán J; López-Ribot JL; Gobernado M
Rev Esp Quimioter; 2002 Mar; 15(1):32-42. PubMed ID: 12582435
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
Ally R; Schürmann D; Kreisel W; Carosi G; Aguirrebengoa K; Dupont B; Hodges M; Troke P; Romero AJ;
Clin Infect Dis; 2001 Nov; 33(9):1447-54. PubMed ID: 11577374
[TBL] [Abstract][Full Text] [Related]
20. To treat or not to treat--critically ill patients with candiduria.
Hollenbach E
Mycoses; 2008 Sep; 51 Suppl 2():12-24. PubMed ID: 18721329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
